MAPT and Alzheimer disease: In the context of this special issue on the Geneva roadmap for early diagnosis of AD based on biomarkers [32], our study contributes to phases 2 and 3 for both Aβ and tau PET imaging assessing the impact of genetics as covariate on biomarker results in healthy controls and in the early phases of disease.